The study shows flotillin levels are preserved in vascular dementia but reduced in AD, suggesting disease-specific mechanisms. This specificity is unexplained but critical for understanding whether flotillin reduction reflects amyloid-specific pathology versus general neurodegeneration processes. Gap type: unexplained_observation Source paper: Flotillin is a Novel Diagnostic Blood Marker of Alzheimer's Disease. (None, None, PMID:31683489)
Landscape Summary: Why does flotillin remain unchanged in vascular dementia but decrease specifically in Alzheimer's disease? is a 0.76 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: open.
Colonna, Sevlever, et al. (TREM2 biology)
Why does flotillin remain unchanged in vascular dementia but decrease specifically in Alzheimer's disease? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: